Targeted fibrosis screening flags fewer adults, upholds low risk for missed liver disease

Researchers have developed a targeted fibrosis screening strategy that reduces the number of adults flagged for testing, doubling case detection while maintaining low risk for future liver disease in those not eligible for screening.Current guidelines from AGA, American Association for the Study of Liver Diseases and European Association for the Study of the Liver identified 60% to 76% of the